At present, all countries in the world deeply affected by the new coronavirus are looking forward to the new coronal vaccine. In the increasingly fierce competition for vaccines, many countries have turned their attention to the international cooperation around the research and development of new vaccines. According to the Straits Times, Indian Foreign Secretary harsh vardhan shringla paid a two-day visit to Dhaka, the capital of Bangladesh, on August 18. During this period, schlingera discussed with Sheikh Hasina, Prime Minister of Bangladesh, the scale and economy of Indian vaccine production in the country. After the meeting, the Ministry of foreign affairs of Bangladesh issued a statement saying: “Bangladesh is ready to cooperate (with India) in the development of a new crown vaccine, and (we) look forward to the early availability of this vaccine when everything is ready.” After the meeting, Masud bin momen, the foreign secretary of Bangladesh, said that India had made a positive response to the joint development of vaccines. “They (India) said that they were not only developing vaccines for themselves, but also developing vaccines for others.” < p > < p > India has the world’s largest vaccine manufacturing company, the Indian Serum Institute. The ability to carry out large-scale vaccine production is a major advantage of India’s vaccine industry. India currently has three new crown vaccines in different stages of testing. Prime Minister modi said on India’s independence day on August 15 that the vaccine would be produced at full speed once it was approved.
today, the novel coronavirus pneumonia cases in Bangladesh and India are not optimistic. As of 19, the number of confirmed cases of new crown pneumonia in Bangladesh has risen to 285091, of which 3781 have died. As for India, novel coronavirus pneumonia is still the world’s more than 3 confirmed number of cases. The number of confirmed cases has exceeded 2 million 830 thousand cases, and 53866 cases have died. < / P > < p > after Russia announced the registration of the world’s first new crown vaccine “Sputnik V” last week, according to the official statement of the country, “more than 20 countries have expressed their interest in purchasing” satellite-v “, and 150 countries are already processing patent applications for Russian vaccines. According to the German voice (DW) report on the 19th, Cuba has joined the production of Russia’s new crown vaccine. Kirill Dmitriev, President of the Russian Direct Investment Fund (rdif), which funded the development of the satellite-v vaccine, said Cuba had excellent vaccine production capacity and “I believe Cuba can become one of the most important vaccine production centers in the world.” Dimitriev pointed out that if Russia cooperates with the Cuban government, the relevant companies will push forward the vaccine production plan as planned. In this case, “satellite-v” vaccine may be produced in Cuba as early as November. However, the details of the cooperation agreement have not yet been finalized. < / P > < p > it is reported that compared with many other developing countries, Cuba has a strong biotechnology sector and its own laboratories. The country’s experience in developing vaccines over the years can be useful in the research of new vaccines. This also makes Cuba a hot spot of transnational cooperation. However, Cuban medical experts are also wary of international cooperation. They believe that although Russia has announced the registration of vaccines, there will not be a large number of effective vaccines for public use in the near future. “Let’s be realistic.” “At present, the only effective way to prevent the virus is to wear masks and abide by the rules of hygiene and social distance,” Francisco Duran, head of the Epidemiology Department of Cuba’s Ministry of public health, told the media